AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2

B. N. Fahy, M. Schlieman, S. Virudachalam, Richard J Bold

Research output: Contribution to journalArticle

96 Scopus citations

Abstract

Activation of the serine/threonine kinase AKT is common in pancreatic cancer, inhibition of which sensitises cells to the apoptotic effect of chemotherapy. Of the various downstream targets of AKT, we examined activation of the NF-κB transcription factor and subsequent transcriptional regulation of BCL-2 gene family in pancreatic cancer cells. Inhibition of either phosphatidylinositol-3 kinase or AKT led to a decreased protein level of the antiapoptotic gene BCL-2 and an increased protein level of the proapoptotic gene BAX. Furthermore, inhibition of AKT decreased the function of NF-κB, which is capable of transcriptional regulation of the BCL-2 gene. Inhibiting this pathway had little effect on the basal level of apoptosis in pancreatic cancer cells, but increased the apoptotic effect of chemotherapy. The antiapoptotic effect of AKT activation in pancreatic cancer cells may involve transcriptional induction of a profile of BCL-2 proteins that confer resistance to apoptosis; alteration of this balance allows sensitisation to the apoptotic effect of chemotherapy.

Original languageEnglish (US)
Pages (from-to)391-397
Number of pages7
JournalBritish Journal of Cancer
Volume89
Issue number2
DOIs
StatePublished - Jul 21 2003

Keywords

  • AKT
  • BCL-2
  • NF-κB
  • Pancreas cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2'. Together they form a unique fingerprint.

  • Cite this